Drugs / CELLULOSE, OXIDIZED
CELLULOSE, OXIDIZED
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT03489070 | Aug 2017 → Jun 2018 | — | China Medical University, China | Completed | No outcome recorded |
| Phase 3 | NCT01407263 | Jul 2011 → Jul 2026 overdue | prostate cancer | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02054260 | ? → Dec 2015 | — | Soonchunhyang University Hospital | Unknown | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CELLULOSE, OXIDIZED | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108268 ↗ |
| Known as | Cellulose, absorbable | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108268 ↗ |
| Known as | Oxidised cellulose | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108268 ↗ |
| Known as | Oxycel | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108268 ↗ |
| Known as | Surgicel | “the operating surgeon may choose to use either Surgicel™, Surgicel SNoW™, Arista™, FloSeal or surgeon's choice HA” NCT01407263 ↗ |
| Modality | Other / unclassified | “Oxidized regenerated cellulose (ORCG)” NCT03489070 ↗ |
| Route | Topical | “applied topically” NCT03489070 ↗ |